PCI Biotech Holding ASA (PCIB) - Total Liabilities

Latest as of June 2025: Nkr6.01 Million NOK ≈ $632.21K USD

Based on the latest financial reports, PCI Biotech Holding ASA (PCIB) has total liabilities worth Nkr6.01 Million NOK (≈ $632.21K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

PCI Biotech Holding ASA - Total Liabilities Trend (2008–2024)

This chart illustrates how PCI Biotech Holding ASA's total liabilities have evolved over time, based on quarterly financial data. See PCI Biotech Holding ASA working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

PCI Biotech Holding ASA Competitors by Total Liabilities

The table below lists competitors of PCI Biotech Holding ASA ranked by their total liabilities.

Company	Country	Total Liabilities
Sejahtera Bintang Abadi Textile Tbk JK:SBAT	Indonesia	Rp495.54 Billion
Wynnstay Properties PLC LSE:WSP	UK	GBX15.13 Million
MSP Recovery, Inc. NASDAQ:MSPR	USA	$2.40 Billion
Global Gas Corporation NASDAQ:HGAS	USA	$322.75K
Virpax Pharmaceuticals Inc NASDAQ:VRPX	USA	$2.47 Million
Jpmorgan Global Core Real Assets Ltd LSE:JARA	UK	GBX282.00K
Baltic Bridge S.A. WAR:WIS	Poland	zł6.36 Million
Cirata plc LSE:CRTA	UK	GBX4.94 Million

Liability Composition Analysis (2008–2024)

This chart breaks down PCI Biotech Holding ASA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PCI Biotech Holding ASA market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.94	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	2.27	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.48	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.32	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how PCI Biotech Holding ASA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for PCI Biotech Holding ASA (2008–2024)

The table below shows the annual total liabilities of PCI Biotech Holding ASA from 2008 to 2024.

Year	Total Liabilities	Change
2024-12-31	Nkr7.76 Million ≈ $816.79K	+55.02%
2023-12-31	Nkr5.01 Million ≈ $526.88K	-17.63%
2022-12-31	Nkr6.08 Million ≈ $639.69K	-72.60%
2021-12-31	Nkr22.19 Million ≈ $2.33 Million	+11.61%
2020-12-31	Nkr19.88 Million ≈ $2.09 Million	-26.93%
2019-12-31	Nkr27.20 Million ≈ $2.86 Million	+59.07%
2018-12-31	Nkr17.10 Million ≈ $1.80 Million	+3.06%
2017-12-31	Nkr16.59 Million ≈ $1.75 Million	+78.20%
2016-12-31	Nkr9.31 Million ≈ $979.89K	-23.14%
2015-12-31	Nkr12.12 Million ≈ $1.27 Million	+7.52%
2014-12-31	Nkr11.27 Million ≈ $1.19 Million	+20.64%
2013-12-31	Nkr9.34 Million ≈ $982.84K	+9.95%
2012-12-31	Nkr8.49 Million ≈ $893.92K	+11.31%
2011-12-31	Nkr7.63 Million ≈ $803.11K	-16.30%
2010-12-31	Nkr9.12 Million ≈ $959.48K	+41.32%
2009-12-31	Nkr6.45 Million ≈ $678.94K	+22.31%
2008-12-31	Nkr5.28 Million ≈ $555.08K	--

About PCI Biotech Holding ASA

OL:PCIB Norway Biotechnology

Market Cap

$274.95K

Nkr2.61 Million NOK

Market Cap Rank

#31037 Global

#273 in Norway

Share Price

Nkr0.07

Change (1 day)

-39.13%

52-Week Range

Nkr0.07 - Nkr1.70

All Time High

Nkr86.30